Neoplastic Plexopathies

Mark Ferrante, John T. Kissel

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Neoplastic processes may involve the cervical, brachial, lumbar, or sacral plexus. Because these four plexuses provide innervation to the shoulder and pelvic girdles and all four extremities, neoplastic plexopathies typically produce significant adverse effects on quality of life. Moreover, when unrecognized, diagnostic and therapeutic delays further negatively affect quality of life and outcome. Although most individuals with neoplastic plexopathies are known to harbor a malignancy or to have advanced neoplastic spread, a minority present with plexus involvement. Thus, to improve quality of life and survival, physicians caring for these patients must understand plexus anatomy, the clinical features associated with neoplastic plexopathies, and the radiologic, oncologic, genetic, and surgical advances in their diagnosis and treatment. Although survival is often less than 2 years, the importance of pain relief, prevention of neuromuscular complications, and maximization of remaining neuromuscular function cannot be overemphasized.

Original languageEnglish (US)
Title of host publicationHandbook of Neuro-Oncology Neuroimaging
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages111-123
Number of pages13
ISBN (Electronic)9780128011683
ISBN (Print)9780128009451
DOIs
StatePublished - Apr 12 2016

Fingerprint

Lumbosacral Plexus
Quality of Life
Neoplastic Processes
Survival
Brachial Plexus
Anatomy
Extremities
Physicians
Pain
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Ferrante, M., & Kissel, J. T. (2016). Neoplastic Plexopathies. In Handbook of Neuro-Oncology Neuroimaging: Second Edition (pp. 111-123). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800945-1.00014-8

Neoplastic Plexopathies. / Ferrante, Mark; Kissel, John T.

Handbook of Neuro-Oncology Neuroimaging: Second Edition. Elsevier Inc., 2016. p. 111-123.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ferrante, M & Kissel, JT 2016, Neoplastic Plexopathies. in Handbook of Neuro-Oncology Neuroimaging: Second Edition. Elsevier Inc., pp. 111-123. https://doi.org/10.1016/B978-0-12-800945-1.00014-8
Ferrante M, Kissel JT. Neoplastic Plexopathies. In Handbook of Neuro-Oncology Neuroimaging: Second Edition. Elsevier Inc. 2016. p. 111-123 https://doi.org/10.1016/B978-0-12-800945-1.00014-8
Ferrante, Mark ; Kissel, John T. / Neoplastic Plexopathies. Handbook of Neuro-Oncology Neuroimaging: Second Edition. Elsevier Inc., 2016. pp. 111-123
@inbook{fdb615f4d13541889ec9bcc7daf5ef15,
title = "Neoplastic Plexopathies",
abstract = "Neoplastic processes may involve the cervical, brachial, lumbar, or sacral plexus. Because these four plexuses provide innervation to the shoulder and pelvic girdles and all four extremities, neoplastic plexopathies typically produce significant adverse effects on quality of life. Moreover, when unrecognized, diagnostic and therapeutic delays further negatively affect quality of life and outcome. Although most individuals with neoplastic plexopathies are known to harbor a malignancy or to have advanced neoplastic spread, a minority present with plexus involvement. Thus, to improve quality of life and survival, physicians caring for these patients must understand plexus anatomy, the clinical features associated with neoplastic plexopathies, and the radiologic, oncologic, genetic, and surgical advances in their diagnosis and treatment. Although survival is often less than 2 years, the importance of pain relief, prevention of neuromuscular complications, and maximization of remaining neuromuscular function cannot be overemphasized.",
author = "Mark Ferrante and Kissel, {John T.}",
year = "2016",
month = "4",
day = "12",
doi = "10.1016/B978-0-12-800945-1.00014-8",
language = "English (US)",
isbn = "9780128009451",
pages = "111--123",
booktitle = "Handbook of Neuro-Oncology Neuroimaging",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Neoplastic Plexopathies

AU - Ferrante, Mark

AU - Kissel, John T.

PY - 2016/4/12

Y1 - 2016/4/12

N2 - Neoplastic processes may involve the cervical, brachial, lumbar, or sacral plexus. Because these four plexuses provide innervation to the shoulder and pelvic girdles and all four extremities, neoplastic plexopathies typically produce significant adverse effects on quality of life. Moreover, when unrecognized, diagnostic and therapeutic delays further negatively affect quality of life and outcome. Although most individuals with neoplastic plexopathies are known to harbor a malignancy or to have advanced neoplastic spread, a minority present with plexus involvement. Thus, to improve quality of life and survival, physicians caring for these patients must understand plexus anatomy, the clinical features associated with neoplastic plexopathies, and the radiologic, oncologic, genetic, and surgical advances in their diagnosis and treatment. Although survival is often less than 2 years, the importance of pain relief, prevention of neuromuscular complications, and maximization of remaining neuromuscular function cannot be overemphasized.

AB - Neoplastic processes may involve the cervical, brachial, lumbar, or sacral plexus. Because these four plexuses provide innervation to the shoulder and pelvic girdles and all four extremities, neoplastic plexopathies typically produce significant adverse effects on quality of life. Moreover, when unrecognized, diagnostic and therapeutic delays further negatively affect quality of life and outcome. Although most individuals with neoplastic plexopathies are known to harbor a malignancy or to have advanced neoplastic spread, a minority present with plexus involvement. Thus, to improve quality of life and survival, physicians caring for these patients must understand plexus anatomy, the clinical features associated with neoplastic plexopathies, and the radiologic, oncologic, genetic, and surgical advances in their diagnosis and treatment. Although survival is often less than 2 years, the importance of pain relief, prevention of neuromuscular complications, and maximization of remaining neuromuscular function cannot be overemphasized.

UR - http://www.scopus.com/inward/record.url?scp=84978358021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978358021&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800945-1.00014-8

DO - 10.1016/B978-0-12-800945-1.00014-8

M3 - Chapter

SN - 9780128009451

SP - 111

EP - 123

BT - Handbook of Neuro-Oncology Neuroimaging

PB - Elsevier Inc.

ER -